Good Sense Sore Throat Spray Recalled for Improper Storage Conditions
Family Dollar Stores recalls Good Sense Sore Throat Spray Cherry 6 FL OZ due to CGMP deviations involving improper storage temperature conditions. The product was distributed nationwide from April 30, 2022 through June 10, 2022.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: This is an FDA Class II recall with no reported illnesses or injuries. The hazard—improper storage temperature—is a manufacturing compliance violation without documented adverse effects, meeting the criteria for a Moderate (2) severity rating.
Plain-English summary
Family Dollar Stores is recalling Good Sense Sore Throat Spray Cherry 6 FL OZ due to manufacturing and quality control deviations. The product was stored outside appropriate temperature conditions, which violates Current Good Manufacturing Practice (CGMP) standards.
The affected product was distributed nationwide to Family Dollar Stores between April 30, 2022 and June 10, 2022. The product SKU is 913018.
No illnesses or injuries have been reported in connection with this recall. Consumers who have purchased this product should discontinue use and consult their healthcare provider with questions about their specific product.
The recalled product
- Product
- GOOD SENSE SORE THROAT SPRAY CHERRY 6 FL OZ distributed to specific Family Dollar Stores 04/30/2022 through 06/10/2022.
- Manufacturer
- Family Dollar Stores, Llc.
- Category
- Drug
- Hazard
- improper-storage
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- SKU: 913018
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- LowPrimidone Tablets Recalled Due to Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27